Journal Articles

A novel approach to chronic wound management using a patented cream of silicon dioxide, silver ions, chlorhexidine and hyaluronic acid

Share this article

A novel approach to chronic wound management using a patented cream of silicon dioxide, silver ions, chlorhexidine and hyaluronic acid

Harikrishna KR Nair, Ling Li Ng, Nur Zati Ilwani
19 October 2021

Chronic wounds with low healing rate generally lead to decreased in quality of life of patients, financial burden and increased morbidity rate (JΓ€rbrink et al, 2016). Thus, wound care management involving a patented 4-in-1 formulation is an aid in the management of chronic wounds. To demonstrate its efficacy, seven patients were chosen, four with a venous leg ulcer, two with a diabetic foot ulcer and 1 with a pressure ulcer. All the wounds were cleaned, debrided and then the silicon dioxide, silver ions, chlorhexidine and hyaluronic acid cream (KAdermin cream) was applied as the primary dressing, with a non-adhesive dressing as a secondary dressing. This case series demonstrates that the cream was able to reduce wound size significantly, while eliminating infection signs.

Free for all healthcare professionals

Sign up to the Wounds Group journals





By clicking β€˜Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.